This country profile provides an overview of South Africa’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profile
Priorities for progress in South Africa
- South Africa has the capacity and potential to provide treatment for bilharzia and intestinal worms.
- It should work to develop a strategy to treat everyone, everywhere, in need of treatment and report in a timely manner to WHO.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
South Africa does not require mass treatment for elephantiasis.
South Africa does not require mass treatment for blinding trachoma.
Treatment coverage decreased from 100% in 2016 to 43% in 2017.
Treatment coverage remained the same at 0% in 2016 and 2017.
South Africa does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in South Africa.